SCHEMBL2908012

SCHEMBL2908012

CCOCc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27404265 0.98 TAAR1 (0.42)
SCHEMBL11224676 0.87 ALOX15 (0.48)
Hydrochloric Acid SCHEMBL11222556 0.85 ALOX15 (0.47)
SCHEMBL27827138 0.84 TAAR1 (0.41)
SCHEMBL27827135 0.81 CYP3A4 (0.49)
SCHEMBL8368761 0.80 TERT (0.44)
SCHEMBL4731585 0.80 ALOX15 (0.41)
SCHEMBL28850765 0.80 CYP1A2 (0.44)
SCHEMBL585992 0.78
SCHEMBL28161824 0.78 CYP1A2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006065842-A2 5,6,7,8-TETRAHYDROQUINOLINES AND RELATED COMPOUNDS AND USES THEREOF SYNTA PHARMACEUTICALS CORP. (US) 2006-06-22 WO claimed
EP-1663227-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS Synta Pharmaceuticals Corporation (US) 2006-06-07 EP claimed
WO-2005025507-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS SYNTA PHAMACEUTICALS CORP. (US) 2005-03-24 WO claimed
US-20260000777-A1 NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF ARARIS BIOTECH AG (CH) 2026-01-01 US disclosed
WO-2022186034-A1 RESIN COMPOSITION FOR CUTTING OFF BLUE LIGHT USING HOLLOW METAL OXIDE PARTICLES, AND USE THEREOF 日本化薬株式会社 2022-09-09 WO disclosed
CN-112174903-B Small molecule modulators of TLR8 清华大学 2022-07-12 CN disclosed
EP-3544627-A1 IMMUNOGENIC COMPOSITIONS COMPRISING SBI PROTEIN AND USES THEREOF The University Of Bath (GB) 2019-10-02 EP disclosed
WO-2018096089-A1 IMMUNOGENIC COMPOSITIONS COMPRISING SBI PROTEIN AND USES THEREOF THE UNIVERSITY OF BATH (GB) 2018-05-31 WO disclosed
US-20180094016-A1 Triazole Compounds And Methods Of Making And Using The Same BioVersys AG (CH) 2018-04-05 US disclosed
US-20180094016-A1 Triazole Compounds And Methods Of Making And Using The Same BioVersys AG (CH) 2018-04-05 US disclosed
EP-1934238-B1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2017-06-28 EP disclosed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO disclosed
US-20030087880-A1 Compound and pharmaceutical composition of antiplasmid effect and the preparation thereof CSAPLAROS, LASZLO (HU) 2003-05-08 US disclosed
EP-1287005-A2 BENZOIC ACID ESTERS HAVING ANTIPLASMID EFFECT Olah, Gabriella (HU) 2003-03-05 EP disclosed
WO-2001093843-A2 BENZOIC ACID ESTERS HAVING ANTIPLASMID EFFECT OLÁH, Gabriella (HU) 2001-12-13 WO disclosed
EP-0561896-A1 USE OF ANGIOTENSN II RECEPTOR ANTAGONISTS FOR THE PREPARATION OF A MEDICAMENT FOR IMPROVING COGNITIVE FUNCTION SMITHKLINE BEECHAM PLC (GB) 1993-09-29 EP disclosed
WO-1992010186-A1 USE OF ANGIOTENSN II RECEPTOR ANTAGONISTS FOR THE PREPARATION OF A MEDICAMENT FOR IMPROVING COGNITIVE FUNCTION SMITHKLINE BEECHAM PLC (GB) 1992-06-25 WO disclosed
US-4831151-A NEMATOCIDES HOFFMANN-LA ROCHE INC. (US) 1989-05-16 US disclosed
CN-86102906-A Preparation 1, the method for the two substituted imidazole  salt of 3- 1987-02-11 CN disclosed
US-4248881-A BACTERICIDES, FUNGICIDES E. R. SQUIBB & SONS, INC. (US) 1981-02-03 US disclosed